RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 23-33
  • Baxter seeks OK to sell new hemophilia drug

    Baxter International on Monday said it had submitted an application to the Food and Drug Administration for the approval of a key hemophilia drug. The drug, BAX 855, is an extended-release version of its flagship hemophilia drug Advate, which is sold...
  • With even some generics rising in price, explore ways to cut your drug costs

    Q: Recently, my doctor prescribed a 10-day course of doxycycline. I always ask for a generic since I need to pay full price. I was shocked when the pharmacist said it would be almost $65. I took this medication three years ago and I think it cost me...
  • Company denies rat poison in pills linked to India sterilization deaths

    Company denies rat poison in pills linked to India sterilization deaths
    The company at the center of a probe into why more than a dozen women died after being sterilized in India has denied that the antibiotic tablets it manufactured were contaminated with a chemical compound commonly found in rat poison. Preliminary tests...
  • Valeant says it's willing to boost offer for Botox maker Allergan

    Valeant says it's willing to boost offer for Botox maker Allergan
    A Canadian company said it is willing to significantly increase its offer for Botox maker Allergan Inc., the latest chapter in the attempted takeover of the Irvine company. Valeant Pharmaceuticals International Inc. said it would be willing to pay up to...
  • Valeant says it's willing to raise offer for Allergan to $200 a share

    As shareholders of Botox maker Allergan Inc. prepare for a vote on the company's future, a Canadian suitor said it's willing to increase its offer to buy the Irvine firm. J. Michael Pearson, chief executive of Valeant Pharmaceuticals International Inc.,...
  • Generic drug prices skyrocket in past year

     Generic drug prices skyrocket in past year
    After calling for a routine prescription refill, Craig Elliott got a rude shock: His bill was going up fivefold. The 44-year-old piano tuner and guitar instructor from Elgin, who has health insurance, used to pay $20 for a three-month supply of his...
  • Energy companies lead an advance in U.S. stocks

    Energy and health-care companies led major stock indexes higher on Tuesday, even as crude oil resumed its slide. General Motors rose after reporting stronger sales, and Biogen, a biotech company, soared following news that its drug for Alzheimer's disease...
  • Japanese firm Otsuka to buy Avanir Pharmaceuticals for $3.5 billion

    The merger wave sweeping the healthcare business caught up another Southern California company Tuesday as Avanir Pharmaceuticals Inc. in Aliso Viejo agreed to be acquired for about $3.5 billion in cash. Japanese drug giant Otsuka Pharmaceutical Co.,...
  • Japanese firm to buy Avanir Pharmaceuticals for $3.5 billion

    Japanese firm to buy Avanir Pharmaceuticals for $3.5 billion
    Avanir Pharmaceuticals Inc. in Aliso Viejo said Tuesday that it has agreed to be acquired by Japanese drug giant Otsuka Pharmaceutical Co. for about $3.5 billion in cash, the latest in a string of mergers sweeping the healthcare sector. Otsuka, a unit...
  • Los Angeles seafood company ordered shut over unsanitary conditions

    A Los Angeles seafood company specializing in smoked and pickled fish was ordered shut by a federal judge over unsanitary conditions. Neptune Manufacturing Inc. can’t reopen until it meets compliance with the U.S. Food and Drug Administration....
  • Dropping coverage of popular prescription drugs is sad and shameful

    Express Scripts, which handles prescription-drug benefits for millions or people nationwide, is dropping coverage for 66 brand-name drugs next month in an effort to keep costs down. Rival CVS Health is dropping 95 drugs from its own list of covered drugs....